(Many people use Ozempic off label for weight loss, though it is not FDA-approved for such.) These medications seem to promote weight loss through two mechanisms that, again, mimic the action of endogenous GLP-1: They delay gastric emptying: The sensation of fullness caused by slower gastric emptying can prompt people to eat less, thus helping them lose weight over time
There are other menstrual irregularities that can occur, potentially affecting your cycle length, flow, and symptomatology
Garber, A
Zepbound is FDA-approved for obesity, while Mounjaro is approved to treat Type 2 diabetes
Then they ran the subgroup analysis
WD increased IWAT (main effect of diet: F( 1, 46 ) = 13.735, p 2 = 0.230, p = 0.001, Fig